Department of Infection Prevention and Control, An-Najah National University Hospital, Nablus, 44839, Palestine.
Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
BMC Infect Dis. 2023 Oct 2;23(1):644. doi: 10.1186/s12879-023-08643-9.
Carbapenem-resistant Enterobacterales (CREs) are a significant source of healthcare-associated infections. These bacteria are difficult to treat and have a high mortality rate due to high rates of antibiotic resistance. These pathogens are also linked to major outbreaks in healthcare institutions especially those with limited resources in infection prevention and control (IPC). Therefore, our study aimed to describe the epidemiology and clinical characteristics of patients with carbapenem-resistant Enterobacteriaceae in a referral hospital in a developing country.
This was a retrospective cross-sectional study that included 218 patients admitted to An-Najah National University Hospital between January 1, 2021, and May 31, 2022. The target population was all patients with CRE infection or colonization in the hospital setting.
Of the 218 patients, 135 had CR-Klebsiella pneumoniae (61.9%), and 83 had CR-Escherichia coli (38.1%). Of these, 135 were male (61.9%) and 83 were female (38.1%), with a median age of 51 years (interquartile range 24-64). Malignancy was a common comorbidity in 36.7% of the patients. Approximately 18.3% of CRE patients were obtained from patients upon admission to the emergency department, the largest percentage among departments. Most CRE pathogens were isolated from rectal swabs, accounting for 61.3%. Among the 218 patients, colistin was the most widely used antimicrobial agent (13.3%). CR- E. coli showed resistance to amikacin in 23.8% of the pathogens tested and 85.7% for trimethoprim/sulfamethoxazole compared to CR- K. pneumonia, for which the resistance to trimethoprim/sulfamethoxazole was 74.1%, while for amikacin it was 64.2%. Regarding meropenem minimum inhibitory concentration, 85.7% of CR- E. coli were greater than 16 µg/mL compared to 84% of CR- K. pneumonia isolates.
This study found that CRE is frequently reported in this tertiary care setting, implying the presence of selective pressure and transmission associated with healthcare setting. The antibiotics tested showed a variety of resistance rates, with CR-K. pneumoniae being more prevalent than CR-E. coli, and exhibiting an extremely high resistance pattern to the available therapeutic options.
耐碳青霉烯肠杆菌科(CRE)是导致医疗保健相关感染的一个重要来源。这些细菌难以治疗,由于抗生素耐药率高,死亡率也很高。这些病原体还与医疗机构的重大疫情有关,特别是那些在感染预防和控制(IPC)方面资源有限的机构。因此,我们的研究旨在描述发展中国家一家转诊医院中耐碳青霉烯肠杆菌科患者的流行病学和临床特征。
这是一项回顾性的横断面研究,共纳入 2021 年 1 月 1 日至 2022 年 5 月 31 日期间入住纳贾赫国立大学医院的 218 名患者。目标人群为医院环境中所有 CRE 感染或定植的患者。
218 名患者中,135 名为耐碳青霉烯肺炎克雷伯菌(61.9%),83 名为耐碳青霉烯大肠埃希菌(38.1%)。其中,135 名为男性(61.9%),83 名为女性(38.1%),中位年龄为 51 岁(四分位间距 24-64)。恶性肿瘤是 36.7%患者的常见合并症。约 18.3%的 CRE 患者是从急诊科入院的患者中获得的,这是科室中比例最大的。大多数 CRE 病原体是从直肠拭子中分离出来的,占 61.3%。在 218 名患者中,多粘菌素是使用最广泛的抗菌药物(13.3%)。CR- E. coli 对阿米卡星的耐药率为 23.8%,对复方磺胺甲噁唑的耐药率为 85.7%,而 CR- K. pneumonia 的复方磺胺甲噁唑耐药率为 74.1%,阿米卡星耐药率为 64.2%。关于美罗培南最低抑菌浓度,85.7%的 CR- E. coli 大于 16µg/ml,而 84%的 CR- K. pneumonia 分离株大于 16µg/ml。
本研究发现,在这个三级保健环境中经常报告 CRE,这意味着存在与医疗保健环境相关的选择性压力和传播。所测试的抗生素显示出不同的耐药率,CR-K. pneumoniae 比 CR-E. coli 更为常见,对现有治疗选择表现出极高的耐药模式。